← Insider buys
CUE

Cue Biopharma, Inc. · Healthcare

Director Anthony Digiandomenico bought $45K of Cue Biopharma, Inc.

Bought$44,900
$4.49Price
10,000Shares
+100%Stake

What CUE did for a copier

Prices for CUE after this filing aren't in yet.

Anthony Digiandomenico's record

11 other buys on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Fri, Dec 21. Filed Wed, Dec 26. Not investment advice.